BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17001539)

  • 1. [Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer].
    Ozgül MA; Uysal MA; Kadakal F; Altoparlak B; Cinemre H; Yilmaz V
    Tuberk Toraks; 2006; 54(3):229-34. PubMed ID: 17001539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
    Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
    Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
    Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
    Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
    Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients.
    Kim SY; Kim JS; Park HS; Cho MJ; Kim JO; Kim JW; Song CJ; Lim SP; Jung SS
    J Korean Med Sci; 2005 Feb; 20(1):121-6. PubMed ID: 15716616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis.
    Yohena T; Yoshino I; Kitajima M; Uehara T; Kanematsu T; Teruya T; Ikeda J; Ichinose Y
    Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):347-9. PubMed ID: 15658906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
    Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
    Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
    Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
    J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
    Balekian AA; Fisher JM; Gould MK
    Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI.
    Yokoi K; Kamiya N; Matsuguma H; Machida S; Hirose T; Mori K; Tominaga K
    Chest; 1999 Mar; 115(3):714-9. PubMed ID: 10084481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of routine brain imaging in the initial management of lung cancer].
    Niviere P; Sculier JP; Meert AP; Berghmans T
    Rev Mal Respir; 2018 Jan; 35(1):55-61. PubMed ID: 29397303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer.
    Na II; Lee TH; Choe DH; Cheon GJ; Kim CH; Koh JS; Baek H; Ryoo BY; Yang SH; Lee JC
    Eur J Cancer; 2008 Nov; 44(16):2411-7. PubMed ID: 18707868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurological examination and brain computed tomography in the initial staging of non-small-cell lung cancer: a prospective study].
    Brichet A; Stach B; Dubois F; Pruvo JP; Duhamel A; Lafitte JJ
    Rev Mal Respir; 1999 Jun; 16(3):361-8. PubMed ID: 10472645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
    Rice SR; Molitoris JK; Vyfhuis MAL; Edelman MJ; Burrows WM; Feliciano J; Nichols EM; Suntharalingam M; Donahue J; Carr SR; Friedberg J; Badiyan S; Simone CB; Feigenberg SJ; Mohindra P
    Clin Lung Cancer; 2019 Jan; 20(1):e107-e114. PubMed ID: 30337268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiologic evaluation in chest malignancies. A review of imaging modalities.
    Pugatch RD
    Chest; 1995 Jun; 107(6 Suppl):294S-297S. PubMed ID: 7781409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?
    Imai K; Kurihara N; Konno M; Mori N; Takashima S; Kuriyama S; Demura R; Suzuki H; Harata Y; Fujibayashi T; Shibano S; Wakita A; Nagaki Y; Sato Y; Nomura K; Minamiya Y
    Cancer Imaging; 2024 Jun; 24(1):69. PubMed ID: 38831467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting extrathoracic metastases in patients with non-small cell lung cancer: Is routine scanning necessary?
    Metintas M; Ak G; Akcayir IA; Metintas S; Erginel S; Alatas F; Yildirim H; Kurt E; Ozkan R
    Lung Cancer; 2007 Oct; 58(1):59-67. PubMed ID: 17566597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer.
    Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma.
    Lee HY; Lee KS; Kim BT; Cho YS; Lee EJ; Yi CA; Chung MJ; Kim TS; Kwon OJ; Kim H
    J Korean Med Sci; 2009 Dec; 24(6):1132-8. PubMed ID: 19949671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.